Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Ranks among the top 35% of all organizations surveyed.
April 21, 2025
By: Charlie Sternberg
Dipharma Francis, a global Contract Development and Manufacturing Organization (CDMO), has once again been awarded a Bronze Medal for its sustainability achievements by EcoVadis, a recognized and independent ratings platform that assesses corporate social responsibility based on international sustainability standards.
EcoVadis has rated Dipharma Francis’s performance among the top 35% of all organizations surveyed, placing the Company in the 66th percentile. The assessment is based on 21 indicators across four key areas: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement.
This recognition reaffirms Dipharma’s ongoing commitment to sustainability and its dedication to integrating responsible practices throughout its operations.
Over the past five years, Dipharma Francis has implemented both technical and managerial solutions that have led to a 20% reduction in greenhouse gas emissions and a 20% reduction in hazardous waste, exceeding its initial target of 15%. Additionally, the company has tripled the share of hazardous waste directed to recycling or recovery rather than disposal.
“This bronze medal is a testament to our continuous efforts to embed sustainability into our business model,” said Marc-Olivier Geinoz, Chairman and Chief Executive Officer of Dipharma Francis S.r.l. “We strive to reduce our environmental footprint, strengthen our ethical governance, and enhance the well-being and safety of our employees, the community, and the patients who use our APIs. This recognition further confirms our commitment not only to delivering high-quality APIs and tailored services, but also to fostering responsible growth.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !